01—Abstract
Summary
Summary of the 10-Q filed August 9, 2024. Cited figures are marked; the original filing is the authoritative source.
UnitedHealth Group (UNH) reported strong revenue growth of 6% for the second quarter of 2024, reaching $98.9 billiona, driven by robust performance in its OptumRx and Optum Health segments, as well as continued growth in UnitedHealthcare's domestic offerings.
Despite the overall revenue increase, net earnings attributable to common shareholders declined by 23% to $4.2 billionb, or $4.54 per diluted share. This decline was primarily due to a significant $1.2 billion loss recognized on the sale of South American operations and a substantial $8.3 billion loss related to the sale of its Brazil operations earlier in the year, alongside impacts from the Change Healthcare cyberattack. The company highlighted continued expansion in its UnitedHealthcare business, serving 1.6 million more people domestically, particularly in commercial offerings and Medicare Advantage.
However, the Change Healthcare cyberattack led to direct response costs of $776 millionc and business disruption impacts of $334 million for the quarter, contributing to increased medical costs and a higher medical care ratio of 85.1%. Looking ahead, UNH is navigating pressures from Medicare Advantage rate reductions and evolving risk adjustment models, while also managing ongoing Medicaid redeterminations.
02—Key points
Key Highlights
- Total revenues increased by 6% to $98.9 billion for the quarter ended June 30, 2024, compared to the prior year, driven by growth in Optum and UnitedHealthcare segments.
- Net earnings attributable to UnitedHealth Group common shareholders decreased by 23% to $4.2 billion ($4.54 per diluted share) for the quarter, impacted by losses on divestitures and the Change Healthcare cyberattack.
- UnitedHealthcare saw a 5% revenue increase and served 1.6 million more people domestically, primarily in commercial and Medicare Advantage offerings, though overall UnitedHealthcare medical membership declined 5% due to divestitures.
- Optum revenues grew 12% driven by Optum Health and Optum Rx, despite a 3% revenue decline and a significant drop in earnings from operations for Optum Insight due to the Change Healthcare cyberattack.
- The company incurred $776 million in direct response costs and $334 million in business disruption impacts from the Change Healthcare cyberattack during the quarter.
- Significant losses were recognized from the sale of Brazil operations ($7.1 billion) and ongoing South American operations held for sale ($1.2 billion) during the first half of 2024.
- The company repurchased 6 million shares for approximately $3.1 billion and increased its quarterly dividend by 11.7% to an annual rate of $8.40 per share.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q2 FY2024, UnitedHealth Group Inc kept $0.04.
- Revenue$98.86B100.0%
- Cost of revenue−$11.34B11.5%
- Gross profit$87.52B88.5%
- Operating costs−$79.64B80.6%
- Operating income$7.88B8.0%
- Interest, other & tax−$3.66B3.7%
- Net income$4.22B4.3%
04—Financials
Financial Highlights
Figures from 10-QQ2 FY2024filed August 9, 2024Financial Statements
Q2 FY2024 against Q2 FY2023
| Line item | Q2 FY2024Q2 FY2023 | Change |
|---|---|---|
| Revenue | $98.86B$92.90B | +6.4% |
| Cost of Revenue | $11.34B$9.75B | +16.3% |
| Gross Profit | $87.52B$83.16B | +5.2% |
| SG&A Expenses | $13.16B$13.81B | −4.7% |
| Operating Expenses | $90.98B$84.85B | +7.2% |
| Operating Income | $7.88B$8.06B | −2.3% |
| Interest Expense | $985.00M$828.00M | +19.0% |
| Net Income | $4.22B$5.47B | −23.0% |
| EPS (Basic) | $4.58$5.89 | −22.2% |
| EPS (Diluted) | $4.54$5.82 | −22.0% |
| Shares Outstanding (Basic) | 921.00M930.00M | −1.0% |
| Shares Outstanding (Diluted) | 928.00M940.00M | −1.3% |
05—Questions
Frequently Asked Questions
What was the primary driver for the decline in net earnings despite revenue growth?
The significant decline in net earnings, down 23% to $4.2 billion, was primarily due to substantial losses recognized from the sale of its Brazil operations ($7.1 billion in the first half) and a $1.2 billion loss on South American operations held for sale in the second quarter. The Change Healthcare cyberattack also contributed to increased response costs and business disruptions.
How did the Change Healthcare cyberattack impact UNH's financial performance?
The cyberattack resulted in $776 million in direct response costs and $334 million in business disruption impacts for the quarter, contributing to higher medical costs and a lower medical care ratio. Optum Insight, in particular, saw a significant decrease in earnings from operations due to these impacts.
What is the outlook for UnitedHealthcare's customer base?
UnitedHealthcare served 1.6 million more people domestically, driven by growth in commercial offerings and Medicare Advantage. However, overall UnitedHealthcare medical membership saw a 5% decline due to divestitures of international operations and ongoing Medicaid redeterminations.
How is UNH managing its capital and returning value to shareholders?
UNH returned value through share repurchases, buying back 6 million shares for approximately $3.1 billion in the first half of the year, and significantly increased its quarterly dividend by 11.7% to an annual rate of $8.40 per share. The company also issued $12 billion in senior unsecured notes in July, adding to its debt and liquidity.
06—Continue